Literature DB >> 18680151

Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function.

Fiona S Anderson1, Alicia S Kunin-Batson.   

Abstract

Advances in the treatment of childhood cancers have greatly improved survivorship. Success has not come without cost, however, as survivors are at risk for late effects of treatment, including neurocognitive late effects (e.g., difficulties with thinking and reasoning). In the advent of chemotherapy-only protocols, researchers are examining neurocognitive sequelae of these agents to understand the specific role of chemotherapy in neurocognitive changes and the mechanism through which these occur. In this review, we examine the state of the literature on neurocognitive late effects after chemotherapy and their proposed neural mechanisms. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680151     DOI: 10.1002/pbc.21700

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  38 in total

1.  Population-based exploration of academic achievement outcomes in pediatric acute lymphoblastic leukemia survivors.

Authors:  Lyndsay A Harshman; Sheila Barron; Anna M Button; Brian J Smith; Brian K Link; Charles F Lynch; Natalie L Denburg
Journal:  J Pediatr Psychol       Date:  2012-01-23

2.  Late effects in cancer survivors: “the shared care model”.

Authors:  Aziza Shad; Scott N Myers; Karen Hennessy
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancers.

Authors:  Marc H Bornstein; Sara Scrimin; Diane L Putnick; Fabia Capello; O Maurice Haynes; Simona de Falco; Modesto Carli; Marta Pillon
Journal:  J Pediatr Psychol       Date:  2012-02-02

Review 4.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

5.  Parents' perspectives of life challenges experienced by long-term paediatric brain tumour survivors: work and finances, daily and social functioning, and legal difficulties.

Authors:  A Fuchsia Howard; Haroon Hasan; Mary Anne Bobinski; Wendy Nurcombe; Robert Olson; Maureen Parkinson; Karen Goddard
Journal:  J Cancer Surviv       Date:  2014-02-22       Impact factor: 4.442

Review 6.  Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.

Authors:  Hilary A Marusak; Allesandra S Iadipaolo; Felicity W Harper; Farrah Elrahal; Jeffrey W Taub; Elimelech Goldberg; Christine A Rabinak
Journal:  Neuropsychol Rev       Date:  2017-12-22       Impact factor: 7.444

7.  Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood.

Authors:  Tami John; Naomi Lomeli; Daniela A Bota
Journal:  Behav Brain Res       Date:  2016-11-13       Impact factor: 3.332

8.  Altered resting state functional connectivity in young survivors of acute lymphoblastic leukemia.

Authors:  Shelli R Kesler; Meike Gugel; Mika Pritchard-Berman; Clement Lee; Emily Kutner; S M Hadi Hosseini; Gary Dahl; Norman Lacayo
Journal:  Pediatr Blood Cancer       Date:  2014-03-12       Impact factor: 3.167

9.  Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.

Authors:  Stephanie L Nassar; Heather M Conklin; Yinmei Zhou; Jason M Ashford; Wilburn E Reddick; John O Glass; Fred H Laningham; Sima Jeha; Cheng Cheng; Ching-Hon Pui
Journal:  Pediatr Blood Cancer       Date:  2017-01-28       Impact factor: 3.167

10.  The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.

Authors:  Kelly M Kenzik; I-Chan Huang; Tara M Brinkman; Brandon Baughman; Kirsten K Ness; Elizabeth A Shenkman; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.